Decreased growth rate of lung metastatic lesions after splenectomy in mice

European Surgical Research

Volumn 38, Issue 5, 2006, Pages 469-475

  Sonoda, Kazuya ^a   Izumi, Koichi ^a   Matsui, Yoko ^a   Inomata, Masafumi ^a   Shiraishi, Norio ^a   Kitano, Seigo ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Angiogenic factors; Lung metastatic lesions; Splenectomy

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER SIZE; COLON CANCER; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; INOCULATION; LUNG METASTASIS; LUNG NODULE; LUNG WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RETICULOENDOTHELIAL SYSTEM; SPLEEN CELL; SPLENECTOMY; TREATMENT OUTCOME;

ADENOCARCINOMA; ANIMALS; CELL PROLIFERATION; COLONIC NEOPLASMS; FEMALE; FIBROBLAST GROWTH FACTORS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; SPLENECTOMY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33750201999     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095415     Document Type: Article

References (33)

1. Brady MS, Rogatko A, Dent LL, Shiu MH: Effect of splenectomy on morbidity and survival following curative gastrectomy for carcinoma. Arch Surg 1991;126:359-364.
2. Griffith JP, Sue-Ling HM, Martin I, Dixon MF, McMahon MJ, Axon AT, Johnston D: Preservation of the spleen improves survival after radical surgery for gastric cancer. Gut 1995;36:684-690.
3. Otsuji E, Yamaguchi T, Sawai K, Ohara M, Takahashi T: End results of simultaneous splenectomy in patients undergoing total gastrectomy for gastric carcinoma. Surgery 1996;120:40-44.
4. Ford EG, Hennessey PJ, Jennings LM, Black T, Andrassy RJ: Gamma-globulin enhances survival in pneumococcal-challenged asplenic infant rats. J Pediatr Surg 1989;24:815-817.
5. Ohshio G, Manabe T, Tobe T, Khine M, Hamashima Y: The effect of splenectomy on antibody response to lipopolysaccharide (E. coli) immunization. J Trauma 1988;28:379-382.
6. Posey DL, Marks C: Overwhelming post-splenectomy sepsis in childhood. Am J Surg 1983;145:318-321.
7. Miwa H, Kojima K, Kobayashi T, Inoue T, Nakamura K, Moriyama M, Oka T, Tsurumi T, Iijima T, Gohchi A, et al: The tumor - immunological significance of splenectomy for cancer therapy (in Japanese). Nippon Geka Gakkai Zasshi 1983;84:970-973.
8. Wanebo HJ, Kennedy BJ, Winchester DP, Stewart AK, Fremgen AM: Role of splenectomy in gastric cancer surgery: adverse effect of elective splenectomy on longterm survival. J Am Coll Surg 1997;185:177-184.
9. Toge T, Kameda A, Kuroi K, Seto Y, Yamada H, Hattori T: The role of the spleen in immunosuppression and the effects of splenectomy on prognosis in gastric cancer patients (in Japanese). Nippon Geka Gakkai Zasshi 1985;86:1120-1123.
10. Saji S, Oshita H, Yamamoto S, Takekoshi T, Sakata K: Experimental study on merits and demerits of splenectomy in tumor bearers. J Surg Oncol 1983;23:35-40.
11. Jessup JM, Pellis NR, Kahan BD: The spleen as a source of nonspecific suppressor cells in the tumor-bearing mouse. J Surg Res 1980;28:460-465.
12. Ojo E: Positive correlation between the levels of natural killer cells and the in vivo resistance to syngeneic tumor transplants as influenced by various routes of administration of Corynebacterium parvum bacteria. Cell Immunol 1979;45:182-187.
13. Hanna N, Burton RC: Definitive evidence that natural killer (NK) cells inhibit experimental tumor metastases in vivo. J Immunol 1981;127:1754-1758.
14. Ferrara N, Davis-Smyth T: The biology of vascular endothelial growth factor. Endocr Rev 1997;18:4-25.
15. Ogawa T, Takayama K, Takakura N, Kitano S, Ueno H: Anti-tumor angiogenesis therapy using soluble receptors: enhanced inhibition of tumor growth when soluble fibroblast growth factor receptor-1 is used with soluble vascular endothelial growth factor receptor. Cancer Gene Ther 2002;9:633-640.
16. Easwaran V, Lee SH, Inge L, Guo L, Goldbeck C, Garrett E, Wiesmann M, Garcia PD, Fuller JH, Chan V, Randazzo F, Gundel R, Warren RS, Escobedo J, Aukerman SL, Taylor RN, Fantl WJ: Beta-catenin regulates vascular endothelial growth factor expression in colon cancer. Cancer Res 2003;63:3145-3153.
17. Voelkel NF, Vandivier RW, Tuder RM: Vascular endothelial growth factor in the lung. Am J Physiol Lung Cell Mol Physiol 2006;290:L209-L221.
18. Nissen NN, Polverini PJ, Koch AE, Volin MV, Gamelli RL, DiPietro LA: Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 1998;152:1445-1452.
19. Cordon-Cardo C, Vlodavsky I, Haimovitz-Friedman A, Hicklin D, Fuks Z: Expression of basic fibroblast growth factor in normal human tissues. Lab Invest 1990;63:832-840.
20. Shiromizu A, Suematsu T, Yamaguchi K, Shiraishi N, Adachi Y, Kitano S: Effect of laparotomy and laparoscopy on the establishment of lung metastasis in a murine model. Surgery 2000;128:799-805.
21. Takayama K, Ueno H, Pei XH, Nakanishi Y, Yatsunami J, Hara N: The levels of integrin alpha v beta 5 may predict the susceptibility to adenovirus-mediated gene transfer in human lung cancer cells. Gene Ther 1998;5:361-368.
22. Brooks SP, Rich GA, Huh YS, Cooney DR: Lymphoid cell populations in splenectomized and nonsplenectomized SJL/J mice bearing Hodgkin's disease-like reticulum cell sarcoma. J Pediatr Surg 1986;21:1114-1118.
23. Schwarz RE, Hiserodt JC: Effects of splenectomy on the development of tumor-specific immunity. J Surg Res 1990;48:448-453.
24. Imai S, Nio Y, Shiraishi T, Tsubono M, Morimoto H, Tseng CC, Kawabata K, Masai Y, Tobe T: Effects of splenectomy on pulmonary metastasis and growth of SC42 carcinoma transplanted into mouse liver. J Surg Oncol 1991;47:178-187.
25. Shiratori Y, Kawase T, Nakata R, Tanaka M, Hikiba Y, Okano K, Matsumura M, Niwa Y, Komatsu Y, Shiina S, et al: Effect of splenectomy on hepatic metastasis of colon carcinoma and natural killer activity in the liver. Dig Dis Sci 1995;40:2398-2406.
26. Suzuki S, Yamanouchi K, Soeta C, Katakai Y, Harada R, Naito K, Tojo H: Skeletal muscle injury induces hepatocyte growth factor expression in spleen. Biochem Biophys Res Commun 2002;292:709-714.
27. Yamashita Y, Jeschke MG, Wolf SE: Differential expression of hepatocyte growth factor in liver, kidney, lung, and spleen following burn in rats. Cytokine 2000;12:1293-1298.
28. Ueda T, Takeyama Y, Yasuda T, Takase K, Nishikawa J, Kuroda Y: Functional alterations of splenocytes in severe acute pancreatitis. J Surg Res 2002;102:161-168.
29. Shaked Y, Cervi D, Neuman M, Chen L, Klement G, Michaud CR, Haeri M, Pak BJ, Kerbel RS, Ben-David Y: The splenic microenvironment is a source of proangiogenesis/inflammatory mediators accelerating the expansion of murine erythroleukemic cells. Blood 2005;105:4500-4507.
30. O'Reilly MS: Angiostatin: an endogenous inhibitor of angiogenesis and of tumor growth. EXS 1997;79:273-294.
31. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J: Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994;79:315-328.
32. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, MacDonald DD, Jin DK, Shido K, Kerns SA, Zhu Z, Hicklin D, Wu Y, Port JL, Altorki N, Port ER, Ruggero D, Shmelkov SV, Jensen KK, Rafii S, Lyden D: VEGFR1-positive haematopoietic bone marrow progenitors initiate the premetastatic niche. Nature 2005;438:820-827.
33. Condon ET, Wang JH, Redmond HP: Surgical injury induces the mobilization of endothelial progenitor cells. Surgery 2004;135:657-661.